title: Endogenous glycosaminoglycan anticoagulation in extracorporeal membrane oxygenation.
abstract: A heparin-like effect was recently described in infants, children, and adults receiving bivalirudin while supported on extracorporeal membrane oxygenation following cardiopulmonary bypass. This is most likely due to endogenous release of glycosaminoglycans from vascular endothelium and mast cells and is associated with longer duration of extracorporeal membrane oxygenation and an increased incidence of sepsis. Further investigation into this effect should include patients without recent cardiopulmonary bypass, exclude the presence of covalent antithrombin-heparin complexes, and employ a variety of different heparinases for thromboelastography. The phenomenon may partially explain the heterogeneity of anticoagulation requirements in patients on extracorporeal life support.
authors: Graeme
authors: G
authors: MacLaren
authors: Paul
authors: P
authors: Monagle
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D006348:Cardiac Surgical Procedures; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects*; D005260:Female; D006629:Hirudins / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology*
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments
references: J Biol Chem. 1997 Aug 29;272(35):22111-7
references: 9268354
references: Thromb Haemost. 2009 Jul;102(1):62-8
references: 19572069
references: Crit Care. 2014;18(5):504
references: 25189998